Showing results (341-350 of 665) with videos related to

Sort By:
Pageof 67
Molecular Cancer Therapeutics|September 26, 2014
Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activityAlison C Macleod, Lillian R Klug, Janice Patterson, et al.
Radiation Oncology (London, England)|January 29, 2017
Helical TomoTherapy for locally advanced or recurrent breast cancerM N Duma, C Heinrich, C Schönknecht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopesI Kurth, U Horsten, S Pflanz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1994
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage siteJ Müllberg, W Oberthür, F Lottspeich, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 29, 2003
IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3Johannes G Bode, Stephan Ludwig, Christina Ehrhardt, et al.
The Journal of Investigative Dermatology|August 1, 1993
UVA-induced autocrine stimulation of fibroblast-derived-collagenase by IL-6: a possible mechanism in dermal photodamage?M Wlaschek, K Bolsen, G Herrmann, et al.
Pageof 67